<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65615</article-id><article-id pub-id-type="doi">10.7554/eLife.65615</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>CD8<sup>+</sup> T cell self-tolerance permits responsiveness but limits tissue damage</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-218344"><name><surname>Truckenbrod</surname><given-names>Emily N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3819-6307</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218343"><name><surname>Burrack</surname><given-names>Kristina S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218345"><name><surname>Knutson</surname><given-names>Todd P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8431-9964</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218347"><name><surname>Borges da Silva</surname><given-names>Henrique</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218348"><name><surname>Block</surname><given-names>Katharine E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235612"><name><surname>O'Flanagan</surname><given-names>Stephen D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218350"><name><surname>Stagliano</surname><given-names>Katie R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218346"><name><surname>Hurwitz</surname><given-names>Arthur A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-218349"><name><surname>Fulton</surname><given-names>Ross B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-170167"><name><surname>Renkema</surname><given-names>Kristin R</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-32785"><name><surname>Jameson</surname><given-names>Stephen C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9137-1146</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Center for Immunology</institution>, <institution>University of Minnesota Medical School</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Minnesota Supercomputing Institute</institution>, <institution>University of Minnesota Medical School</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">NIAID</institution>, <institution>NIH</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Immunology</institution>, <institution>Agentus Therapeutics</institution>, <addr-line><named-content content-type="city">Lexington</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Grand Valley State University</institution>, <addr-line><named-content content-type="city">Allendale</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-18113"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing editor</role><aff><institution>The University of Queensland</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>renkemak@gvsu.edu</email> (KR);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>james024@umn.edu</email> (SJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>04</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e65615</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>04</month><year>2021</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65615-v1.pdf"/><abstract><p>Self-specific CD8+ T cells can escape clonal deletion, but the properties and capabilities of such cells in a physiological setting are unclear. We characterized polyclonal CD8<sup>+</sup> T cells specific for the melanocyte antigen tyrosinase-related protein 2 (Trp2) in mice expressing or lacking this enzyme (due to deficiency in <italic>Dct</italic>, which encodes Trp2). Phenotypic and gene expression profiles of pre-immune Trp2/K<sup>b</sup>-specific cells were similar; the size of this population was only slightly reduced in wild-type (WT) compared to <italic>Dct</italic>-deficient (<italic>Dct</italic><sup>-/-</sup>) mice. Despite comparable initial responses to Trp2 immunization, WT Trp2/K<sup>b</sup>-specific cells showed blunted expansion and less readily differentiated into a CD25+ proliferative population. Functional self-tolerance clearly emerged when assessing immunopathology: adoptively transferred WT Trp2/K<sup>b</sup>-specific cells mediated vitiligo much less efficiently. Hence, CD8<sup>+</sup> T cell self-specificity is poorly predicted by precursor frequency, phenotype or even initial responsiveness, while deficient activation-induced CD25 expression and other gene expression characteristics may help to identify functionally tolerant cells.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01AI140631</award-id><principal-award-recipient><name><surname>Jameson</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>P01AI035296</award-id><principal-award-recipient><name><surname>Jameson</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Arthur A Hurwitz, Arthur A Hurwitz is affiliated with AgenTus Therapeutics, Inc. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf3"><p>Ross B Fulton, Ross B. Fulton is affiliated with HiFiBio, Inc. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals and handled according to protocols approved but the University of Minnesota IACUC (#1709-35136A and #2007-38243A).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>NextGen sequencing data has being deposited at GEO: Code GSE171221.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Truckenbrod EN</collab><collab>Burrack KS</collab><collab>Knutson TP</collab><collab>Borges da Silva H</collab><collab>Block KE</collab><collab>Stagliano KR</collab><collab>Hurwitz AA</collab><collab>Fulton RB</collab><collab>Renkema KR</collab><collab>Jameson SC</collab></person-group><year iso-8601-date="2021">2021</year><source>Non-deletional CD8+ T cell self-tolerance permits responsiveness but limits tissue damage</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171221">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171221</ext-link><comment>NCBI Gene Expression Omnibus, GSE171221</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-65615-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>